LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,665 | +8.4% | 27,783 | +30.4% | 0.02% | +33.3% |
| Q2 2023 | $1,536 | +27.3% | 21,310 | +18.0% | 0.01% | -33.3% |
| Q4 2022 | $1,207 | -99.8% | 18,063 | +220.2% | 0.02% | +200.0% |
| Q3 2022 | $486,000 | +38.5% | 5,642 | +145.3% | 0.01% | +20.0% |
| Q1 2021 | $351,000 | -42.7% | 2,300 | -62.7% | 0.01% | -16.7% |
| Q4 2020 | $613,000 | +94.0% | 6,165 | +86.1% | 0.01% | 0.0% |
| Q3 2020 | $316,000 | -71.0% | 3,312 | -66.0% | 0.01% | -78.6% |
| Q2 2020 | $1,091,000 | – | 9,751 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |